Page last updated: 2024-09-04

resiquimod and Caliciviridae Infections

resiquimod has been researched along with Caliciviridae Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Enosi Tuipulotu, D; Lun, JH; Mackenzie, JM; Netzler, NE; White, PA1
Abt, MC; Artis, D; Becattini, S; Buffie, CG; Carter, RA; Keith, JW; Leiner, I; Osborne, LC; Pamer, EG; SuĊĦac, B1

Other Studies

2 other study(ies) available for resiquimod and Caliciviridae Infections

ArticleYear
TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Aminoquinolines; Animals; Antiviral Agents; Caliciviridae Infections; Cell Line; Guanosine; Humans; Imidazoles; Imiquimod; Mice; Pteridines; RAW 264.7 Cells; Toll-Like Receptor 7; Virus Replication

2018
TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus.
    Science translational medicine, 2016, Feb-24, Volume: 8, Issue:327

    Topics: Ampicillin; Animals; Caliciviridae Infections; CD11c Antigen; Colony Count, Microbial; Dendritic Cells; Drug Resistance, Bacterial; Enterococcus; Gastroenteritis; Imidazoles; Interferon Type I; Interleukin-1; Interleukin-22; Interleukin-23; Interleukins; Ligands; Mice, Inbred C57BL; Norovirus; Pancreatitis-Associated Proteins; Proteins; Signal Transduction; Toll-Like Receptor 7; Vancomycin

2016